The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Inhibition of mitochondrial fragmentation diminishes Huntington’s disease–associated neurodegeneration
Open accessAbstract
Huntington's disease (HD) is the result of expression of a mutated Huntingtin protein (mtHtt), and is associated with a variety of cellular dysfunctions including excessive mitochondrial fission. Here, we tested whether inhibition of excessive mitochondrial fission prevents mtHtt-induced pathology. We developed a selective inhibitor (P110-TAT) of the mitochondrial fission protein dynamin-related protein 1 (DRP1). We found that P110-TAT inhibited mtHtt-induced excessive mitochondrial fragmentation, improved mitochondrial function, and increased cell viability in HD cell culture models. P110-TAT treatment of fibroblasts from patients with HD and patients with HD with iPS cell-derived neurons reduced mitochondrial fragmentation and corrected mitochondrial dysfunction. P110-TAT treatment also reduced the extent of neurite shortening and cell death in iPS cell-derived neurons in patients with HD. Moreover, treatment of HD transgenic mice with P110-TAT reduced mitochondrial dysfunction, motor deficits, neuropathology, and mortality. We found that p53, a stress gene involved in HD pathogenesis, binds to DRP1 and mediates DRP1-induced mitochondrial and neuronal damage. Furthermore, P110-TAT treatment suppressed mtHtt-induced association of p53 with mitochondria in multiple HD models. These data indicate that inhibition of DRP1-dependent excessive mitochondrial fission with a P110-TAT-like inhibitor may prevent or slow the progression of HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“For example, p53 can induce the expression of some downstream targets, such as Bax and Puma, which lead to apoptosis in HD cell models (75). p53 can also enter the mitochondrial matrix to induce oxidative stress through interaction with p66 SHC and MnSOD (76, 77).”
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,405
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Quantification of histochemical staining by color deconvolution.
Ruifrok, A. C. C., & Johnston, D. A. (2001) · PubMed · Cited by 2,029
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in Apoptosis
Frank, S., Gaume, B., Bergmann-Leitner, E. S., Leitner, W. W., Robert, E. G., Catez, F., Smith, C. L., & Youle, R. J. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00055-7 · Cited by 1,755
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Otera, H., Wang, C., Cleland, M. M., Setoguchi, K., Yokota, S., Youle, R. J., & Mihara, K. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201007152 · Cited by 1,110 · cited 1×
“Drp1 binds to mitochondrial adaptors, such as Fis1, Mff, and MiD49/51, thus assembling future fission sites and severing mitochondrial membranes in a GTP hydrolysis-dependent fission (14–17).”
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Mitochondrial fragmentation in neurodegeneration.
Knott, A. B., Perkins, G., Schwarzenbacher, R., & Bossy-Wetzel, E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2417 · Cited by 1,002
Mitochondrial Fusion and Fission in Mammals
Chan, D. C. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104638 · Cited by 972
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Slow, E. J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg169 · Cited by 800
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
hFis1, a Novel Component of the Mammalian Mitochondrial Fission Machinery
James, D. I., Parone, P. A., Mattenberger, Y., & Martinou, J.-C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303758200 · Cited by 652
MiD49 and MiD51, new components of the mitochondrial fission machinery
Palmer, C. S., Osellame, L. D., Laine, D., Koutsopoulos, O. S., Frazier, A. E., & Ryan, M. T. (2011) · The EMBO Reports · doi:10.1038/embor.2011.54 · Cited by 649
Vaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
Trettel, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2799 · Cited by 610
Dynamic regulation of mitochondrial fission through modification of the dynamin‐related protein Drp1
Chang, C., & Blackstone, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05629.x · Cited by 567
Song, W., Chen, J., Petrilli, A., Liot, G., Klinglmayr, E., Zhou, Y., Poquiz, P., Tjong, J., Pouladi, M. A., Hayden, M. R., et al. (2011) · Nature Medicine · doi:10.1038/nm.2313 · Cited by 555
Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508
Oxidative stress in Huntington’s disease
Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508
The HD iPSC Consortium (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.027 · Cited by 490
p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.005 · Cited by 485
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
Tsunemi, T., Ashe, T. D., Morrison, B. E., Soriano, K. R., Au, J., Roque, R. A. V., Lazarowski, E. R., Damian, V. A., Masliah, E., & La Spada, A. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003799 · Cited by 442
Novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity
Qi, X., Qvit, N., Su, Y.-C., & Mochly-Rosen, D. (2012) · Journal of Cell Science · doi:10.1242/jcs.114439 · Cited by 439
Self-citationSomers, A., Jean, J.-C., Sommer, C. A., Omari, A., Ford, C. C., Mills, J. A., Ying, L., Sommer, A. G., Jean, J. M., Smith, B. W., et al. (2010) · Stem Cells · doi:10.1002/stem.495 · Cited by 423
Conformational changes in Dnm1 support a contractile mechanism for mitochondrial fission
Mears, J. A., Lackner, L. L., Fang, S., Ingerman, E., Nunnari, J., & Hinshaw, J. E. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1949 · Cited by 418
Shirendeb, U. P., Calkins, M. J., Manczak, M., Anekonda, V., Dufour, B., McBride, J. L., Mao, P., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr475 · Cited by 383
Zhao, J., Liu, T., Jin, S., Wang, X., Qu, M., Uhlén, P., Tomilin, N., Shupliakov, O., Lendahl, U., & Nistér, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.198 · Cited by 370
Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases
Reddy, P. H., Reddy, T. P., Manczak, M., Calkins, M. J., Shirendeb, U., & Mao, P. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.11.004 · Cited by 363
Li, J., Donath, S., Li, Y., Qin, D., Prabhakar, B. S., & Li, P. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000795 · Cited by 361
Disturbed Ca2+signaling and apoptosis of medium spiny neurons in Huntington's disease
Tang, T.-S., Slow, E., Lupu, V., Stavrovskaya, I. G., Sugimori, M., Llinás, R., Kristal, B. S., Hayden, M. R., & Bezprozvanny, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409402102 · Cited by 360
Canals, J. M., Pineda, J. R., Torres-Peraza, J. F., Bosch, M., Martín-Ibañez, R., Muñoz, M. T., Mengod, G., Ernfors, P., & Alberch, J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1197-04.2004 · Cited by 345
Progress toward the clinical application of patient-specific pluripotent stem cells
Kiskinis, E., & Eggan, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40553 · Cited by 339
Germain, M., Mathai, J. P., McBride, H. M., & Shore, G. C. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600592 · Cited by 337
Mitochondrial fission proteins regulate programmed cell death in yeast
Fannjiang, Y., Cheng, W.-C., Lee, S. J., Qi, B., Pevsner, J., McCaffery, J. M., Hill, R. B., Basañez, G., & Hardwick, J. M. (2004) · Genes & Development · doi:10.1101/gad.1247904 · Cited by 304
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 289
Costa, V., Giacomello, M., Hudec, R., Lopreiato, R., Ermak, G., Lim, D., Malorni, W., Davies, K. J. A., Carafoli, E., & Scorrano, L. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000102 · Cited by 288
Monoubiquitylation promotes mitochondrial p53 translocation
Marchenko, N. D., Wolff, S., Erster, S., Becker, K., & Moll, U. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601560 · Cited by 286
Qi, X., Disatnik, M.-H., Shen, N., Sobel, R. A., & Mochly-Rosen, D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0551 · Cited by 258
Self-citationCharacterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
Zhang, N., An, M. C., Montoro, D., & Ellerby, L. M. (2010) · PLoS Currents · doi:10.1371/currents.rrn1193 · Cited by 253
Sharpless, N. E., & DePinho, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00818-8 · Cited by 250
Zhao, Y., Chaiswing, L., Velez, J. M., Batinic-Haberle, I., Colburn, N. H., Oberley, T. D., & St. Clair, D. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3835 · Cited by 245
Liot, G., Bossy, B., Lubitz, S., Kushnareva, Y., Sejbuk, N., & Bossy-Wetzel, E. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.22 · Cited by 241
de Almeida, L. P., Ross, C. A., Zala, D., Aebischer, P., & Déglon, N. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03473.2002 · Cited by 224
Effects of overexpression of Huntingtin proteins on mitochondrial integrity
Wang, H., Lim, P. J., Karbowski, M., & Monteiro, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn404 · Cited by 224
Su, Y.-C., & Qi, X. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt301 · Cited by 222
Self-citationZhu, P.-P., Patterson, A., Stadler, J., Seeburg, D. P., Sheng, M., & Blackstone, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404105200 · Cited by 220
Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease
Zischka, H., Lichtmannegger, J., Schmitt, S., Jägemann, N., Schulz, S., Wartini, D., Jennen, L., Rust, C., Larochette, N., Galluzzi, L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45401 · Cited by 215
Protein Kinase C δ Mediates Cerebral Reperfusion Injury In Vivo
Bright, R., Raval, A. P., Dembner, J. M., Pérez-Pinzón, M. A., Steinberg, G. K., Yenari, M. A., & Mochly-Rosen, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4474-03.2004 · Cited by 198
Self-citationJeon, I., Lee, N., Li, J.-Y., Park, I.-H., Park, K. S., Moon, J., Shim, S. H., Choi, C., Chang, D.-J., Kwon, J., et al. (2012) · Stem Cells · doi:10.1002/stem.1135 · Cited by 197
Reddy, P. H., & Shirendeb, U. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.016 · Cited by 188
Gharami, K., Xie, Y., An, J. J., Tonegawa, S., & Xu, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05137.x · Cited by 184
Camnasio, S., Carri, A. D., Lombardo, A., Grad, I., Mariotti, C., Castucci, A., Rozell, B., Riso, P. L., Castiglioni, V., Zuccato, C., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.042 · Cited by 173
Han, I., You, Y., Kordower, J. H., Brady, S. T., & Morfini, G. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06672.x · Cited by 172
Oliveira, J. M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06741.x · Cited by 163
Shaping the role of mitochondria in the pathogenesis of Huntington's disease
Costa, V., & Scorrano, L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.65 · Cited by 161
Coutellier, L. D., Beraki, S., Ardestani, P. M., Saw, N. L., & Shamloo, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046604 · Cited by 118
Self-citationFaizi, M., Bader, P. L., Saw, N. L., Nguyen, T. V., Beraki, S., Wyss‐Coray, T., Longo, F. M., & Shamloo, M. (2012) · Brain and Behavior · doi:10.1002/brb3.41 · Cited by 108
Self-citationGunaseeli, I., Doss, M. X., Antzelevitch, C. N., Hescheler, J., & Sachinidis, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790514480 · Cited by 104
Qi, X., & Mochly‐Rosen, D. (2008) · Journal of Cell Science · doi:10.1242/jcs.024653 · Cited by 101
Self-citationGalluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 87
Mitochondrial respiratory control is lost during growth factor deprivation
Gottlieb, E., Armour, S. M., & Thompson, C. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202477599 · Cited by 83
Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice
Simmons, D. A., Mehta, R. A., Lauterborn, J. C., Gall, C. M., & LYNCH, G. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.015 · Cited by 81
Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration
Oettinghaus, B., Licci, M., Scorrano, L., & Frank, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0930-z · Cited by 71
Protein misfolding inside cells: The case of huntingtin and Huntington's disease
Hatters, D. M. (2008) · IUBMB Life · doi:10.1002/iub.111 · Cited by 70
Qi, X., Inagaki, K., Sobel, R. A., & Mochly‐Rosen, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32636 · Cited by 61
Self-citationCellular Therapy and Induced Neuronal Replacement for Huntington's Disease
Benraiss, A., & Goldman, S. A. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0075-8 · Cited by 58
Role of MnSOD and p66shc in Mitochondrial Response to p53
Pani, G., & Galeotti, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3499 · Cited by 56
Wang, D. B., Garden, G. A., Kinoshita, C., Wyles, C. C., Babazadeh, N., Sopher, B. L., Kinoshita, Y., & Morrison, R. S. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3365-12.2013 · Cited by 55
Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 54
Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Melone, M. A. B., Jori, F. P., & Peluso, G. (2005) · Current Drug Targets · doi:10.2174/1389450053344975 · Cited by 53
Castiglioni, V., Onorati, M., Rochon, C., & Cattaneo, E. F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.032 · Cited by 44
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
Switonski, P. M., Szlachcic, W. J., Gabka, A., Krzyżosiak, W. J., & Figiel, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8316-3 · Cited by 40
Neurobiology of Huntington's Disease: Applications to Drug Discovery
Lo, D. C., & Hughes, R. E. (2010) · CRC Press eBooks · doi:10.1201/ebk0849390005 · Cited by 40
Mouse Models for Validating Preclinical Candidates for Huntington's Disease
Yang, X. W., & Gray, M. (2010) · Frontiers in neuroscience · doi:10.1201/ebk0849390005-c7 · Cited by 32
Id, M., Jovanović, Čolić, M. J., Mihajlovic, R., Mićić, D., Selaković, V., Ninković, M., Maličević, Ž., Rusić-Stojiljković, M., & Jovicic, A. (2001) · PubMed · Cited by 25
Cited by
The cell biology of mitochondrial membrane dynamics
Giacomello, M., Pyakurel, A., Glytsou, C., & Scorrano, L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0210-7 · Cited by 1,550
Mitochondrial Dynamics and Its Involvement in Disease
Chan, D. C. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032711 · Cited by 1,416
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
Redox Homeostasis and Mitochondrial Dynamics
Willems, P. H. G. M., Rossignol, R., Dieteren, C. E. J., Murphy, M. P., & Koopman, W. J. H. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.006 · Cited by 859
Distinct fission signatures predict mitochondrial degradation or biogenesis.
Kleele, T., Rey, T., Winter, J., Zaganelli, S., Mahecic, D., Perreten Lambert, H., Ruberto, F. P., Nemir, M., Wai, T., Pedrazzini, T., et al. (2021) · Nature · doi:10.1038/s41586-021-03510-6 · Cited by 794
Metadata
- Authors
- Guo, X., Disatnik, M.-H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-11-15
- Volume
- 123
- Issue
- 12
- Pages
- 5371-5388
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2010369463
- Cited by
- 370
- References
- 92
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.